Why Does Dance Therapy Work So Well for Parkinson Patients?
In her academic paper “Dance as Therapy for Individuals with Parkinson Disease,” published in the “European Journal of Physical and Rehabilitation Medicine,” Gammon M. Earhart, an Associate Professor of Physical Therapy at Washington University’s School of Medicine, finds that Parkinson’s disease patients have much to gain in a dance program.
http://ping.fm/Onx6T
Friday, August 5, 2011
Thursday, August 4, 2011
SHARE YOUR STORY: Clinical Trials
When diagnosed with a disease not yet curable, patients, caregivers and loved ones are faced with a colossal decision: whether or not to participate in experimental treatments and clinical trials.
http://ping.fm/XqusY
When diagnosed with a disease not yet curable, patients, caregivers and loved ones are faced with a colossal decision: whether or not to participate in experimental treatments and clinical trials.
http://ping.fm/XqusY
Wednesday, August 3, 2011
CoQ10: Larger Studies Still Needed
Researchers continue to explore the efficacy of Co-Enzyme Q10 (CoQ10) in aiding Parkinson’s treatments. Coenzyme Q10 (CoQ10) is produced by the human body and is necessary for the basic functioning of cells.
http://ping.fm/I2vdn
Researchers continue to explore the efficacy of Co-Enzyme Q10 (CoQ10) in aiding Parkinson’s treatments. Coenzyme Q10 (CoQ10) is produced by the human body and is necessary for the basic functioning of cells.
http://ping.fm/I2vdn
CoQ10: Larger Studies Still Needed
Researchers continue to explore the efficacy of Co-Enzyme Q10 (CoQ10) in aiding Parkinson’s treatments. Coenzyme Q10 (CoQ10) is produced by the human body and is necessary for the basic functioning of cells.
CoQ10 levels are reported to decrease with age. In many patients with chronic diseases, including PD, low levels of CoQ10 are often reported. Supplemental forms of CoQ10 are available by traditional vitamin distributors, and can even be found at the grocery store.
Unfortunately, research has yet to confirm whether taking CoQ10 as a supplement offers any relief from PD. Larger studies with human subjects are still needed to offer conclusive evidence either way.
What are your thoughts on CoQ10? Do you take the supplement?
http://ping.fm/VpciQ
Researchers continue to explore the efficacy of Co-Enzyme Q10 (CoQ10) in aiding Parkinson’s treatments. Coenzyme Q10 (CoQ10) is produced by the human body and is necessary for the basic functioning of cells.
CoQ10 levels are reported to decrease with age. In many patients with chronic diseases, including PD, low levels of CoQ10 are often reported. Supplemental forms of CoQ10 are available by traditional vitamin distributors, and can even be found at the grocery store.
Unfortunately, research has yet to confirm whether taking CoQ10 as a supplement offers any relief from PD. Larger studies with human subjects are still needed to offer conclusive evidence either way.
What are your thoughts on CoQ10? Do you take the supplement?
http://ping.fm/VpciQ
Tuesday, August 2, 2011
Cannabis as a Treatment for PD?
According to a new study published in the scientific journal British Journal of Pharmacology, cannabis’ active components show promise in slowing the progression of Parkinson’s symptoms .
An international team of researchers from Spain and Israel assessed the potential of cannabinoids to slow the progression of both Huntington’s disease (HD) and Parkinson’s disease (PD), both of which are considered inadequately managed by conventional treatment therapies.
Researchers noted that both THC and cannabidiol (CBD) were observed to “protect nigral or striatal neurons in experimental models of both disorders.” Investigators added that the separate “activation of CB(2) [cannabinoid] receptors leads to a slower progression of neurodegeneration in both disorders.”
Authors concluded, “Evidence reported so far supports that those cannabinoids having antioxidant properties and/or capability to activate CB(2) receptors may represent promising therapeutic agents in HD and PD, thus deserving a prompt clinical evaluation.”
http://ping.fm/mVhOb
According to a new study published in the scientific journal British Journal of Pharmacology, cannabis’ active components show promise in slowing the progression of Parkinson’s symptoms .
An international team of researchers from Spain and Israel assessed the potential of cannabinoids to slow the progression of both Huntington’s disease (HD) and Parkinson’s disease (PD), both of which are considered inadequately managed by conventional treatment therapies.
Researchers noted that both THC and cannabidiol (CBD) were observed to “protect nigral or striatal neurons in experimental models of both disorders.” Investigators added that the separate “activation of CB(2) [cannabinoid] receptors leads to a slower progression of neurodegeneration in both disorders.”
Authors concluded, “Evidence reported so far supports that those cannabinoids having antioxidant properties and/or capability to activate CB(2) receptors may represent promising therapeutic agents in HD and PD, thus deserving a prompt clinical evaluation.”
http://ping.fm/mVhOb
Monday, August 1, 2011
Drug Concerns for Parkinson’s Patients
According to an article recently published in the Wall Street Journal, powerful anti-psychotic drugs are routinely prescribed to elderly people with Parkinson's disease, despite warnings about the associated risks of using this type of medication when treating aging populations.
Most well known for affecting motor function, symptoms of Parkinson’s disease extend past the physical realm. Documented occurrences of psychological disturbances are often reported in patients during the later stages of PD, compounding the typical changes that occur in the aging mind.
There are currently no PD-specific anti-psychotic drugs, leaving doctors with a guessing game as to which drugs best treat Parkinson-induced psychotic symptoms. Many doctors are turning to a family of drugs with approved uses for schizophrenia and other psychotic conditions; drugs which contain little or no clinical basis for efficacy in treating PD symptoms.
The article urges clinicians to become more educated on what they are prescribing, but stresses that it is ultimately up to the patient and caregiver to be passionately engaged in their care.
http://ping.fm/Oeppa
According to an article recently published in the Wall Street Journal, powerful anti-psychotic drugs are routinely prescribed to elderly people with Parkinson's disease, despite warnings about the associated risks of using this type of medication when treating aging populations.
Most well known for affecting motor function, symptoms of Parkinson’s disease extend past the physical realm. Documented occurrences of psychological disturbances are often reported in patients during the later stages of PD, compounding the typical changes that occur in the aging mind.
There are currently no PD-specific anti-psychotic drugs, leaving doctors with a guessing game as to which drugs best treat Parkinson-induced psychotic symptoms. Many doctors are turning to a family of drugs with approved uses for schizophrenia and other psychotic conditions; drugs which contain little or no clinical basis for efficacy in treating PD symptoms.
The article urges clinicians to become more educated on what they are prescribing, but stresses that it is ultimately up to the patient and caregiver to be passionately engaged in their care.
http://ping.fm/Oeppa
Drug Concerns for Parkinson’s Patients
According to an article recently published in the Wall Street Journal, powerful anti-psychotic drugs are routinely prescribed to elderly people with Parkinson's disease, despite warnings about the associated risks of using this type of medication when treating aging populations.
Most well known for affecting motor function, symptoms of Parkinson’s disease extend past the physical realm. Documented occurrences of psychological disturbances are often reported in patients during the later stages of PD, compounding the typical changes that occur in the aging mind.
There are currently no PD-specific anti-psychotic drugs, leaving doctors with a guessing game as to which drugs best treat Parkinson-induced psychotic symptoms. Many doctors are turning to a family of drugs with approved uses for schizophrenia and other psychotic conditions; drugs which contain little or no clinical basis for efficacy in treating PD symptoms.
The article urges clinicians to become more educated on what they are prescribing, but stresses that it is ultimately up to the patient and caregiver to be passionately engaged in their care.
http://ping.fm/WMKnd
According to an article recently published in the Wall Street Journal, powerful anti-psychotic drugs are routinely prescribed to elderly people with Parkinson's disease, despite warnings about the associated risks of using this type of medication when treating aging populations.
Most well known for affecting motor function, symptoms of Parkinson’s disease extend past the physical realm. Documented occurrences of psychological disturbances are often reported in patients during the later stages of PD, compounding the typical changes that occur in the aging mind.
There are currently no PD-specific anti-psychotic drugs, leaving doctors with a guessing game as to which drugs best treat Parkinson-induced psychotic symptoms. Many doctors are turning to a family of drugs with approved uses for schizophrenia and other psychotic conditions; drugs which contain little or no clinical basis for efficacy in treating PD symptoms.
The article urges clinicians to become more educated on what they are prescribing, but stresses that it is ultimately up to the patient and caregiver to be passionately engaged in their care.
http://ping.fm/WMKnd
Subscribe to:
Posts (Atom)